Product Information

METFORMIN HCL 750 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $14.6050 per EA under NDC 62135068230. Its NADAC has been published 29 times since Dec 10, 2025.

The High Outlier badge above means this manufacturer's average price in the Metformin Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

METFORMIN HCL 750 MG TABLET

Metformin Hydrochloride
$14.6050per EA
High Outlier

Strength

750 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135068230

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

12/17/2025

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075972

On Market Since

1/24/2002

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN HCL 750 MG TABLET has been published 29 times since Dec 10, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$14.6050 per EA
All-time high$14.6050 (Jun 24, 2026)
All-time low$14.6050 (Dec 10, 2025)
52-week high$14.6050
52-week low$14.6050
Median price$14.6050
Average price$14.6050
Largest weekly change0.0% (Dec 17, 2025)
Weeks tracked29
Tracking sinceDec 10, 2025

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METFORMIN HCL 750 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 750 MG TABLET, manufactured by Chartwell RX LLC, is $14.6050 per EA (NDC 62135068230), effective Jun 24, 2026.

How has the price of METFORMIN HCL 750 MG TABLET changed over time?

Over the history we have for it, the NADAC for METFORMIN HCL 750 MG TABLET has held within roughly two percent of its current level. It has been tracked across 29 weekly CMS publications since Dec 10, 2025.

What are the highest and lowest recorded NADAC prices for METFORMIN HCL 750 MG TABLET?

Since Dec 10, 2025, the NADAC for METFORMIN HCL 750 MG TABLET has ranged from a low of $14.6050 (Dec 10, 2025) to a high of $14.6050 (Jun 24, 2026), with a median of $14.6050 per EA.

Are there cheaper alternatives to METFORMIN HCL 750 MG TABLET?

Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METFORMIN HCL ER 750 MG TABLET, is $0.0546 per EA — about 100% below METFORMIN HCL 750 MG TABLET.

Who manufactures METFORMIN HCL 750 MG TABLET?

METFORMIN HCL 750 MG TABLET (NDC 62135068230) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.